EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access

Mortality and Morbidity in Adults With Rheumatic Heart Disease

Ganesan Karthikeyan, Mpiko Ntsekhe, Shofiqul Islam, Sumathy Rangarajan, Alvaro Avezum, Alexander Benz, Tantchou Tchoumi Jacques Cabral, Ma Changsheng, Philly Chillo, J Antonio Gonzalez-Hermosillo, Bernard Gitura, Albertino Damasceno und 20 weitere

JAMA · 09.07.2024 · 332 (2) · 133

DOI: 10.1001/jama.2024.8258 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JAMA, erschienen am 09.07.2024. Verfasst von Ganesan Karthikeyan und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, All India Institute of Medical Sciences, New Delhi. Hauptthemen laut MEDLINE: Cause of Death, Developing Countries, Rheumatic Heart Disease. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Rheumatic heart disease (RHD) remains a public health issue in low- and middle-income countries (LMICs). However, there are few large studies enrolling individuals from multiple endemic countries.

Objective

To assess the risk and predictors of major patient-important clinical outcomes in patients with clinical RHD. Design, Setting, and Participants Multicenter, hospital-based, prospective observational study including 138 sites in 24 RHD-endemic LMICs. Main Outcomes and Measures The primary outcome was all-cause mortality. Secondary outcomes were cause-specific mortality, heart failure (HF) hospitalization, stroke, recurrent rheumatic fever, and infective endocarditis. This study analyzed event rates by World Bank country income groups and determined the predictors of mortality using multivariable Cox models.

Results

Between August 2016 and May 2022, a total of 13 696 patients were enrolled. The mean age was 43.2 years and 72% were women. Data on vital status were available for 12 967 participants (94.7%) at the end of follow-up. Over a median duration of 3.2 years (41 478 patient-years), 1943 patients died (15% overall; 4.7% per patient-year). Most deaths were due to vascular causes (1312 [67.5%]), mainly HF or sudden cardiac death. The number of patients undergoing valve surgery (604 [4.4%]) and HF hospitalization (2% per year) was low. Strokes were infrequent (0.6% per year) and recurrent rheumatic fever was rare. Markers of severe valve disease, such as congestive HF (HR, 1.58 [95% CI, 1.50-1.87]; P < .001), pulmonary hypertension (HR, 1.52 [95% CI, 1.37-1.69]; P < .001), and atrial fibrillation (HR, 1.30 [95% CI, 1.15-1.46]; P < .001) were associated with increased mortality. Treatment with surgery (HR, 0.23 [95% CI, 0.12-0.44]; P < .001) or valvuloplasty (HR, 0.24 [95% CI, 0.06-0.95]; P = .042) were associated with lower mortality. Higher country income level was associated with lower mortality after adjustment for patient-level factors. Conclusions and Relevance Mortality in RHD is high and is correlated with the severity of valve disease. Valve surgery and valvuloplasty were associated with substantially lower mortality. Study findings suggest a greater need to improve access to surgical and interventional care, in addition to the current approaches focused on antibiotic prophylaxis and anticoagulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cause of DeathDeveloping CountriesRheumatic Heart DiseaseAdultFemaleHumansMaleMiddle AgedEndocarditisHeart FailureHospitalizationMorbidityProportional Hazards ModelsProspective StudiesRheumatic FeverStroke

Autor:innen und Institutionen

  • Department of Cardiology, All India Institute of Medical Sciences, New Delhi.
  • Translational Health Science and Technology Institute, Faridabad, India.
  • Division of Cardiology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
  • International Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.
  • Department of Cardiology, University Medical Center Mainz, Johannes Gutenberg University Mainz, Mainz, Germany.

Förderung

  • Medical Research Council

Zitieren

APA

Karthikeyan, G., Ntsekhe, M., Islam, S., Rangarajan, S., Avezum, A., Benz, A., Cabral, T. T. J., Changsheng, M., Chillo, P., Gonzalez-Hermosillo, J. A., Gitura, B., Damasceno, A., Dans, A. M. L., Davletov, K., Elghamrawy, A., ElSayed, A., Fana, G. T., Gondwe, L., Haileamlak, A., …, & INVICTUS Investigators (2024). Mortality and Morbidity in Adults With Rheumatic Heart Disease. JAMA, 332(2), 133. https://doi.org/10.1001/jama.2024.8258

Vancouver

Karthikeyan G, Ntsekhe M, Islam S, Rangarajan S, Avezum A, Benz A, et al. Mortality and Morbidity in Adults With Rheumatic Heart Disease. JAMA. 2024;332(2):133. doi:10.1001/jama.2024.8258

BibTeX
@article{Karthikeyan2024,
  author = {Karthikeyan, Ganesan and Ntsekhe, Mpiko and Islam, Shofiqul and Rangarajan, Sumathy and Avezum, Alvaro and Benz, Alexander and Cabral, Tantchou Tchoumi Jacques and Changsheng, Ma and Chillo, Philly and Gonzalez-Hermosillo, J Antonio and Gitura, Bernard and Damasceno, Albertino and Dans, Antonio Miguel L and Davletov, Kairat and Elghamrawy, Alaa and ElSayed, Ahmed and Fana, Golden Tafadzwa and Gondwe, Lillian and Haileamlak, Abraham and Kayani, Azhar Mahmood and Lwabi, Peter and Maklady, Fathi and Molefe-Baikai, Onkabetse Julia and Musuku, John and Ogah, Okechukwu Samuel and Paniagua, Maria and Rusingiza, Emmanuel and Sharma, Sanjib Kumar and Zuhlke, Liesl and Connolly, Stuart and Yusuf, Salim and INVICTUS Investigators, INVICTUS Investigators},
  title = {Mortality and Morbidity in Adults With Rheumatic Heart Disease},
  journal = {JAMA},
  year = {2024},
  volume = {332},
  number = {2},
  pages = {133},
  doi = {10.1001/jama.2024.8258}
}
Kostenlos starten →